نتایج جستجو برای: cytochrome p450 enzyme system

تعداد نتایج: 2476970  

Journal: :American family physician 2007
Tom Lynch Amy Price

Cytochrome P450 enzymes are essential for the metabolism of many medications. Although this class has more than 50 enzymes, six of them metabolize 90 percent of drugs, with the two most significant enzymes being CYP3A4 and CYP2D6. Genetic variability (polymorphism) in these enzymes may influence a patient's response to commonly prescribed drug classes, including beta blockers and antidepressant...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 1997
B Clement M Demesmaeker

The in vitro N-hydroxylation of guanabenz as well as the corresponding N-dehydroxylation of guanoxabenz has been previously detected in biotransformation studies with microsomal fractions of different species including human hepatic microsomes. Furthermore, the N-hydroxylation of guanabenz was found to be catalyzed by enriched cytochrome P450 (P450) fractions in reconstituted systems. Strong co...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 1997
N Masubuchi H Hakusui O Okazaki

The effects of pantoprazole on xenobiotic metabolizing enzymes in rat liver microsomes were examined. Groups of female Sprague-Dawley rats were orally administered pantoprazole and other proton pump inhibitors, omeprazole and lansoprazole, at 5, 50, or 300 mg/kg/day for 7 days, followed by assays to detect changes in the levels of liver microsomal protein, cytochrome P450, cytochrome b5, NADPH ...

Journal: :Current opinion in green and sustainable chemistry 2023

Cytochrome P450 monooxygenases (CYPs/P450s) are heme-thiolate proteins with broad chemical functionality that have widespread application as powerful biocatalysts given their high stereo- and regio-selectivity. A large variety of value-added compounds, including pharmaceuticals natural products, can be synthesized by P450s, often superior selectivity at milder conditions than counterparts makin...

Journal: :The Journal of biological chemistry 2013
Courtney M Krest Elizabeth L Onderko Timothy H Yosca Julio C Calixto Richard F Karp Jovan Livada Jonathan Rittle Michael T Green

Recently, we reported the spectroscopic and kinetic characterizations of cytochrome P450 compound I in CYP119A1, effectively closing the catalytic cycle of cytochrome P450-mediated hydroxylations. In this minireview, we focus on the developments that made this breakthrough possible. We examine the importance of enzyme purification in the quest for reactive intermediates and report the preparati...

Journal: :Comparative biochemistry and physiology. Part C, Pharmacology, toxicology & endocrinology 1998
P J den Besten

The results of a limited number of studies on echinoderms provide evidence for the presence of a cytochrome P450 monooxygenase system in representatives of three classes of the phylum Echinodermata: the asteroids (sea stars), holothuroids (sea cucumbers) and echinoids (sea urchins). The monooxygenase system has been demonstrated to be involved in the metabolism of xenobiotic compounds, but is a...

Journal: :The Journal of biological chemistry 2003
Gareth A Roberts Ayhan Celik Dominic J B Hunter Tobias W B Ost John H White Stephen K Chapman Nicholas J Turner Sabine L Flitsch

p450 RhF from Rhodococcus sp. NCIMB 9784 is the first example of a new class of cytochrome p450 in which electrons are supplied by a novel, FMN- and Fe/S-containing, reductase partner in a fused arrangement. We have previously cloned the gene encoding the enzyme and shown it to comprise an N-terminal p450 domain fused to a reductase domain that displays similarity to the phthalate family of oxy...

Journal: :The Journal of antimicrobial chemotherapy 2007
Mark-David Levin Jan G den Hollander Bronno van der Holt Bart J Rijnders Martin van Vliet Pieter Sonneveld Ron H N van Schaik

OBJECTIVES Voriconazole, like all other antifungals of the azole group, is potentially hepatotoxic. A large interpatient variability of liver enzyme elevations during oral or intravenous (iv) voriconazole administration is observed. This interpatient variability may be explained by differences in voriconazole metabolism because of cytochrome P450 polymorphisms. We examined the relationship betw...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2005
Namandjé N Bumpus Chitra Sridar Ute M Kent Paul F Hollenberg

The polymorphic human cytochrome P450 (P450) 2B6 is primarily responsible for the metabolism of several clinically relevant drugs including bupropion, cyclophosphamide, propofol, and efavirenz. Although a number of single nucleotide polymorphisms have been found in the P450 2B6 gene, the influence of these variants on the metabolism of substrates and on the response to known inactivators of P45...

Journal: :Experimental oncology 2005
I M Danko N A Chaschin

We summarize research results on association of cytochrome P450 2E1 (CYP2E1) genetic polymorphisms with the development of ecologically determined cancers. Cytochrome P450 monooxygenase enzyme system is involved in metabolic activation of procarcinogens, which is an important stage during normal cell transformation into a malignant one. Studies of association between CYP2E1 gene polymorphisms a...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید